2 Minute Medicine Rewind February 20, 2017
Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer First line treatment for patients with advanced, non-small cell lung cancers that...
Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer First line treatment for patients with advanced, non-small cell lung cancers that...
Trial of amitriptyline, topiramate, and placebo for pediatric migraine The management of migraine headaches in the pediatric population has always...
Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions Recent...
Adjuvant sunitinib in high-risk renal cell carcinoma after nephrectomy Sunitinib is a vascular endothelial growth factor pathway inhibitor used for...
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis Celecoxib is a selective COX-2 inhibitor used for analgesia as an...
United States Health Care Reform: Progress to Date and Next Steps The Affordable Care Act was passed in 2010...
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma Merkel cell is a relatively slow-growing but aggressive skin cancer with...
Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation Pulmonary vein isolation is often attempted as an interventional approach for drug-refractory...
Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease Patients with chronic kidney disease...
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer The management of locally advanced squamous cell head and...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.